Retrophin, Inc.
(NASDAQ : RTRX)

( )
RTRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.04%202.891.3%$439.73m
BIIBBiogen Inc.
1.14%225.761.3%$382.28m
GILDGilead Sciences, Inc.
0.81%64.510.9%$362.26m
CELGCelgene Corporation
-0.18%100.391.3%$352.37m
ILMNIllumina, Inc.
2.56%310.313.5%$266.69m
REGNRegeneron Pharmaceuticals, Inc.
1.55%305.442.6%$219.74m
EXASExact Sciences Corporation
2.54%94.8524.1%$199.38m
ALXNAlexion Pharmaceuticals, Inc.
2.11%101.342.0%$181.06m
VRTXVertex Pharmaceuticals Incorporated
0.68%173.591.9%$178.83m
AAgilent Technologies, Inc.
-0.16%75.181.6%$153.77m
SRPTSarepta Therapeutics, Inc.
2.66%85.7014.6%$141.72m
ALDRAlder Biopharmaceuticals, Inc.
0.27%18.9210.2%$132.33m
BMRNBioMarin Pharmaceutical Inc.
-0.18%67.244.3%$95.95m
ACADACADIA Pharmaceuticals Inc.
-2.57%39.4813.4%$89.57m
SGENSeattle Genetics, Inc.
-0.22%82.426.2%$84.75m

Company Profile

Retrophin, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. Its products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 8, 2008 and is headquartered in San Diego, CA.